$HBAN

ROLLINS JAMES D III sold $3.9M of HBAN

ROLLINS JAMES D III sold 223,522 shares of HUNTINGTON BANCSHARES INC /MD/ (HBAN) at $17.35 ($3.88M total) on 2026-06-12.

Original reporting
SEC EDGAR · ROLLINS JAMES D III
Published Jun 16, 2026, 8:52 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 16, 2026, 9:02 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$HBAN
Neutral
medium confidence
Mentioned
$HBAN
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HBANNeutralLow
01

Why it matters

This disclosure updates the record of insider ownership and may marginally influence sentiment, but it does not introduce new operating or financial information.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone is unlikely to change valuation without accompanying fundamental news.

03

What to watch

The article does not state whether the sale was part of a 10b5-1 plan (it says no), but it also provides no context on total compensation, prior holdings, or whether other insiders sold/bought around the same time.

Relevance 6/10Novelty 6/10Timing: filed 2026-06-16 (Form 4) for a sale dated 2026-06-12

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for Huntington Bancshares (HBAN).

Company-level read

Ticker impact

$HBANNeutralMedium confidence
Context

SEC Form 4 shows director James D. Rollins sold 223,522 HBAN shares in an open-market transaction on 2026-06-12.

Expected impact

Likely limited/short-lived impact; any move would be more sentiment/flow-driven than fundamental.

Evidence & confidence

The filing is a routine Form 4 open-market sale with no 10b5-1 plan stated; however, the article provides no earnings, guidance, or operational catalyst.

Market effects

No sector-level read-across; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Director sales can be driven by diversification, taxes, or pre-planned liquidity needs rather than bearish expectations.

Key entities

  • Huntington Bancshares Inc

    HBAN, the company whose director sold shares via an open-market sale.

  • James D. Rollins III

    Director who sold 223,522 shares at $17.35 on 2026-06-12.

Related articles

$HBANMed

Huntington Bancshares Q2 Earnings Call Highlights

Huntington Bancshares management said it is on track for $365 million in Cadence cost synergies in Q4 and $435 million in combined Veritex and Cadence run-rate expense synergies by Q4. Q2 average loans rose $15B (8.6%) and deposits rose $18.8B (9.2%). Net interest income was $2.1B (+8.5%); value-added fees rose over 60% YoY. Outlook: NII pressured by deposit costs; EPS target for 2027 is $1.90 to $1.93.

$HBANMed

HUNTINGTON BANCSHARES INC /MD/ (HBAN): Results of Operations and Financial Condition

HUNTINGTON BANCSHARES INC /MD/ (HBAN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 hban20260630_8kex992.htm EX-99.2 Document Exhibit 99.2 HUNTINGTON BANCSHARES INCORPORATED Quarterly Financial Supplement June 30, 2026 Table of Contents Quarterly Key Statistics 1 Year-to-Date Key Statistics 2 Consolidated Balance Sheets 4 Loans and Leases Composition 5